Publications by authors named "M Coraglio"
Article Synopsis
- The study aimed to evaluate the Immunoscore (IS) as a potential biomarker for patients with rectal cancer managed by a watch-and-wait (W&W) strategy, focusing on predicting recurrence after treatment.
- It involved 249 patients and analyzed the presence of specific immune cells in pre-treatment biopsies, finding that higher IS scores were associated with better 5-year recurrence-free rates.
- The results indicate that IS is a strong independent predictor of time to recurrence and improves the accuracy of clinical models in assessing patient outcomes.
Anal squamous cell carcinoma (ASCC) is a rare malignancy with a rising incidence associated with human papillomavirus (HPV) infection. The locally advanced disease is associated with a 30% rate of treatment failure after standard chemoradiotherapy (CRT). We aimed to elucidate the prognostic factors for ASCC after curative CRT.
View Article and Find Full Text PDFRecently, biallelic germline variants of the DNA glycosylase genes and were linked to polyposis susceptibility. Significant fractions remain without a molecular explanation, warranting searches for underlying causes. We used exome sequencing to investigate clinically well-defined adenomatous polyposis cases and families from Finland (N=34), Chile (N=21), and Argentina (N=12), all with known susceptibility genes excluded.
View Article and Find Full Text PDFRectal Cancer (RC) is a complex disease that involves highly variable treatment responses. Currently, there is a lack of reliable markers beyond TNM to deliver a personalized treatment in a cancer setting where the goal is a curative treatment. Here, we performed an integrated characterization of the predictive and prognostic role of clinical features, mismatch-repair deficiency markers, HER2, CDX2, PD-L1 expression, and CD3CD8 tumor-infiltrating lymphocytes (TILs) coupled with targeted DNA sequencing of 76 non-metastatic RC patients assigned to total mesorectal excision upfront (TME; n = 15) or neoadjuvant chemo-radiotherapy treatment (nCRT; n = 61) followed by TME.
View Article and Find Full Text PDFBetter quality of life and reduced fecal incontinence in rectal cancer patients with the watch-and-wait follow-up strategy.
Rev Gastroenterol Mex (Engl Ed)
October 2021
Introduction: The watch-and-wait (WW) strategy is an alternative to anterior resection in patients with rectal cancer (RC) that have had a complete clinical response to neoadjuvant treatment. Few reports describe the quality of life and functional anorectal disorders (FADs) in that population.
Aim: To analyze and compare the FADs and quality of life in patients with locally advanced adenocarcinoma of the rectum treated with neoadjuvant therapy, divided into two different strategy groups: group 1 (G1), WW; and group 2 (G2), anterior resection.